This site is intended for Healthcare Professionals only.

Tag: Glenmark Pharmaceuticals Limited; Dipeptidyl Peptidase 4 inhibitor; fixed-dose combination; type 2 diabetes; Remogliflozin-Vildagliptin-Metformin


Glenmark launches tablet to control type 2 diabetes in India which costs just £0.16

Glenmark Pharmaceuticals has launched a fixed-dose combination drug for the management of type 2 diabetes patients in India which costs just £0.16 per tablet. According...